Page 460 - 先天性心脏病的导管术:从婴幼儿期到成人期
P. 460

442                                       先天性心脏病的导管术:从婴幼儿期到成人期


                 mature infants: who really benefits, and at what cost? J Pediatr Surg. 2007;42(1):69-75.

                 discussion 75
             [22] Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory im-
                 pairment after surgical closure of patent ductus arteriosus in extremely low birth weight
                 infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr.

                 2007;150(3):229-234.e1.
             [23] Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treat-
                 ment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics.
                 2007;119(6):1165-74.

             [24] Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a me-
                 ta-analysis. Pediatrics. 2014;133(4):e1024-46.
             [25] Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neona-
                 tal treatment options better or worse than no treatment at all? Semin Perinatol.

                 2012;36(2):123-9.
             [26] Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, VanHoestenberghe M-R,
                 Theyskens C. Conservative treatment for patentductus arteriosus in the preterm. Arch
                 Dis Child Fetal Neonatal Ed. 2007;92(4):F244-7.

             [27] Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G. What happens
                 when the patent ductus arteriosus is treated less aggressively in very low birth weight
                 infants? J Perinatol. 2012;32(5):344-8.
             [28] Sung SI, Chang YS, Chun JY, Yoon SA, Yoo HS, Ahn SY, et al. Mandatory closure

                 versus nonintervention for patent ductus arteriosus in very pre-term infants. J Pediatr.
                 2016;177:66-71.e1.
             [29] Wickremasinghe AC, Rogers EE, Piecuch RE, Johnson BC, Golden S, Moon-Grady
                 AJ, et al. Neurodevelopmental outcomes following two different treatment ap-

                 proaches (early ligation and selective ligation) for patent ductus arteriosus. J Pediatr.
                 2012;161(6):1065-72.
             [30] Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S, et al. Spontaneous closure
                 of patent ductus arteriosus in infants </=1500 g. Pediatrics. 2017;140(2):e20164258.

             [31] Slaughter JL, Reagan PB, Newman TB, Klebanoff MA. Comparative effectiveness of
                 nonsteroidal anti-inflammatory drug treatment vs notreatment for patent ductus arterio-
                 sus in preterm infants. JAMA Pediatr. 2017;171(3):e164354.
             [32] Benitz WE, Slaughter JL, Reagan PB, Newman TB, Klebanoff MA, Semberova J, et al.
   455   456   457   458   459   460   461   462   463   464   465